[1] Sciubba JJ, Goldenberg D.Oral complications of radiotherapy[J]. Lancet Oncol, 2006, 7(2): 175-183.
[2] Lyons A, Ghazali N.Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment[J]. Br J Oral Maxillofac Surg, 2008, 46(8): 653-660.
[3] Shaw R, Tesfaye B, Bickerstaff M, et al.Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (hyperbaric oxygen for the prevention of osteoradionecrosis)[J]. Oral Oncol, 2017, 64(1): 73-77.
[4] Lyons AJ, Brennan PA.Pentoxifylline - a review of its use in osteoradionecrosis[J]. Br J Oral Maxillofac Surg, 2017, 55(3): 230-234.
[5] Fang SL, Kong XB, Chen W, et al.Proteomic analysis of serum in patients with osteoradionecrosis of the jaws[J]. Int Dent J, 2012, 62(S1):24.
[6] Fang SL, Chen W, Wang SY, et al.Identification of differential proteins that related to bone metabolism in the serum of ORNJ patients[J]. Int Dent J, 2012, 62(S1):25.
[7] Uskokovic A, Dinic S, Mihailovic M, et al.STAT3/NFkappaB interplay in the regulation of alpha2-macroglobulin gene expression during rat liver development and the acute phase response[J]. IUBMB Life, 2007, 59(3): 170-178.
[8] 刘仰, 孔祥波, 李洁, 等. α2巨球蛋白减轻X射线所致人骨髓间充质干细胞成骨分化障碍[J]. 中国病理生理杂志, 2017, 33(11): 2032-2037.
[9] Monson LA, Jing XL, Donneys A, et al.Dose-response effect of human equivalent radiation in the mandible[J]. J Craniofac Surg, 2013, 24(5): 1593-1598.
[10] Lyons A, Osher J, Warner E, et al.Osteoradionecrosis--a review of current concepts in defining the extent of the disease and a new classification proposal[J]. Br J Oral Maxillofac Surg, 2014, 52(5): 392-395.
[11] Rivero JA, Shamji O, Kolokythas A.Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, alpha-tocopherol, and clodronate[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017, 124(5): 464-471.
[12] Raguse JD, Hossamo J, Tinhofer I, et al. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016, 121(3): 215-221.e1.
[13] Blery P, Espitalier F, Hays A, et al.Development of mandibular osteoradionecrosis in rats: Importance of dental extraction[J]. J Craniomaxillofac Surg, 2015, 43(9): 1829-1836.
[14] Manzon L, Rossi E, Fratto G.Management of osteonecrosis of the jaws induced by radiotherapy in oncological patients: preliminary results[J]. Eur Rev Med Pharmacol Sci, 2015, 19(2): 194-200.
[15] Rehman AA1, Zaman M2, Zia MK, et al. Conformational behavior of alpha-2-macroglobulin:Aggregation and inhibition induced by TFE[J]. Int J Biol Macromol, 2017, 104(Pt A): 539-546.
[16] Siddiqui T, Zia MK, Ali SS, et al.Reactive oxygen species and anti-proteinases[J]. Arch Physiol Biochem, 2016,122(1): 1-7.
[17] Chen X, Kong X, Zhang Z, et al.Alpha-2-macroglobulin as a radioprotective agent: a review[J]. Chin J Cancer Res, 2014, 26(5): 611-621.
[18] Bogojevic D, Poznanovic G, Grdovic N, et al.Administration of rat acute-phase protein alpha(2)-macroglobulin before total-body irradiation initiates cytoprotective mechanisms in the liver[J]. Radiat Environ Biophys, 2011, 50(1): 167-179.
[19] Mirjana M, Goran P, Nevena G, et al.The rat acute-phase protein alpha2-macroglobulin plays a central role in amifostine-mediated radioprotection[J]. J Radiol Prot, 2010, 30(3): 567-583.
[20] Wang Y, Zhu G, Wang J, et al.Irradiation alters the differentiation potential of bone marrow mesenchymal stem cells[J]. Mol Med Rep, 2016, 13(1): 213-223. |